How sleep relates to HIV medication use and viral control
Characterizing Sleep, ART Adherence and Viral Suppression
Young men with HIV will wear a small wrist device to track sleep over a year so researchers can link sleep patterns to taking HIV medicines and controlling the virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11402525 on NIH RePORTER |
What this research studies
If you join, you would be one of 250 men already in the Neighborhoods and Networks (N2) cohort who wear a wrist actigraph for two weeks at the start and again twice more over a year. The study will combine the sleep recordings with clinic data on HIV treatment, medicine-taking, viral load results, and visits to see how sleep and other life factors relate to staying in care and keeping the virus suppressed. Researchers will also look at things like body weight, relationship violence, and how close you live to health services to see if those change the sleep–HIV links. The goal is to find patterns that could point to real-world ways to help people take medicines and keep viral load low.
Who could benefit from this research
Good fit: Ideal candidates are HIV-positive men in the N2 cohort who are willing to wear a wrist actigraph for three two-week periods over a year and share clinical data on ART use and viral loads.
Not a fit: People who are HIV-negative, not men in the targeted cohort, or unwilling/unable to wear the wrist device or share clinical data are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could point to sleep-based or related supports that help people stick to HIV treatment and maintain viral suppression.
How similar studies have performed: Previous studies linking sleep to HIV outcomes often used self-reported sleep and have mixed results, and objective sleep tracking in men with HIV is largely new and untested.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Duncan, Dustin T — Columbia University Health Sciences
- Study coordinator: Duncan, Dustin T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.